Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$42.76 USD
+0.02 (0.05%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $42.79 +0.03 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IONS 42.76 +0.02(0.05%)
Will IONS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IONS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IONS
Ionis Stock Drops 12% on Pricing of $500M Common Stock Offering
Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?
IONS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
Other News for IONS
January 2027 Options Now Available For Ionis Pharmaceuticals (IONS)
Stock moves reflect downgrade for US economic growth outlook - Goldman
January 2026 Options Now Available For Ionis Pharmaceuticals
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today